Programs, populations, and payments verified via SAMHSA.
- Level of care
- IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Anger management, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Special populations
- Adult women, Adult men, Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Methadone, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (extended-release, injectable), Medications for HIV treatment, Medications for Hepatitis C treatment, Medications for pre-exposure to prophylaxis, Medication for mental disorders
- Recovery supports
- Housing services, Assistance with obtaining social services, Mentoring/peer support
- Facility operation
- Private non-profit organization